Business
AngioDynamics to Host Virtual Cardiovascular Investor Event
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy
About this update from Angiodynamics, Inc.
[{"type":"text","content":" LATHAM, N.Y.--(BUSINESS WIRE)--\nAngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, will host a virtual cardiovascular investor event this Wednesday, April 2, 2025 at 9:00am ET. The event will take place immediately following the Company’s Fiscal 2025 Third Quarter Financial Results Conference Call which will start at 8:00am ET the same day.\n\nVirtual Cardiovascular Investor Event\n\nDate: Wednesday, April 2, 2025\nTime: 9:00am ET\nDuration: 60 minutes\n\nWebcast Registration Link: https://viavid.webcasts.com/starthere.jsp?ei=1712212&tp_key=cedf6b19b1\n\nEvent Overview\n\nAngioDynamics will provide investors a deeper dive into the cardiovascular technology portfolio and strategic vision.\n\nThe event will be webcast and can be accessed through the \"Investors\" section of the AngioDynamics website at www.angiodynamics.com.\n\nAbout AngioDynamics, Inc.\n\nAngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.\n\nThe Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250331827841/en/\n\nInvestors:\n\nAngioDynamics, Inc.\nStephen Trowbridge, Executive Vice President & CFO\n(518) 795-1408\[email protected]\n\nMedia:\n\nSaleem Cheeks\nVice President, Communications\n518-795-1174\[email protected]\n\nSource: AngioDynamics, Inc.","length":4182,"tagName":"div"}]